Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreGlucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreEditor’s NoteDiabetes and eating disorders: Dr Beth SheltonDieting and children: Dr Laura HartPart 2: Video interview with Royal Children’s Hospital nurse Claire MayUpcoming events – ANZAED Autumn workshops Editor’s NoteWelcome to a new year and a new start in 2021.
Read moreA Pharmacist is often the first health professional that a person with an eating disorder will come in contact with.
Read more